SCOLIOSIS RESEARCH SOCIETY

EIN: 237181863 501(c)(3)

MILWAUKEE, WI

Total Revenue
$6,307,257
Total Expenses
$5,632,098
Total Assets
$21,328,808
Net Assets
$20,911,494
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1966
Legal Domicile
IL
Principal Officer
SERENA HU MD
Phone
4142899107
Tax Period
2023-01-01 to 2023-12-31

SCOLIOSIS RESEARCH SOCIETY, founded in 1966, is a community nonprofit that reported $6.3M in total revenue in fiscal year 2023. Revenue decreased 19% compared to the prior year. Expenses of $5.6M left a modest 11% surplus.

Mission

THE PURPOSE OF THE SCOLIOSIS RESEARCH SOCIETY IS TO FOSTER THE OPTIMAL CARE OF ALL PATIENTS WITH SPINAL DEFORMITIES.

Program Service Accomplishments

Program 1
Expenses: $1,136,427 Revenue: $1,003,304

IMAST (INTERNATIONAL MEETING ON ADVANCED SPINE TECHNIQUES) PROVIDES AN INTERNATIONAL SCIENTIFIC FORUM FOR SPINE PROFESSIONALS TO STAY UP-TO-DATE ON EMERGING NEW TECHNOLOGIES AND TECHNIQUES. SPINE...

Read more

IMAST (INTERNATIONAL MEETING ON ADVANCED SPINE TECHNIQUES) PROVIDES AN INTERNATIONAL SCIENTIFIC FORUM FOR SPINE PROFESSIONALS TO STAY UP-TO-DATE ON EMERGING NEW TECHNOLOGIES AND TECHNIQUES. SPINE SURGEONS AND OTHER ALLIED HEALTH PROFESSIONAL FROM AROUND THE WORLD DISCUSS, DEBATE, AND DEMONSTRATE RECENT ADVANCES IN SPINE SURGERY.

Program 2
Expenses: $1,651,343 Revenue: $1,879,058

THE ANNUAL MEETING AND COURSE IS A FORUM FOR THE REALIZATION OF THE SOCIETY'S MISSION AND GOALS, THE IMPROVEMENT OF PATIENT CARE FOR THOSE WITH SPINAL DEFORMITIES. PRESENTATIONS AT THE ANNUAL MEETING...

Read more

THE ANNUAL MEETING AND COURSE IS A FORUM FOR THE REALIZATION OF THE SOCIETY'S MISSION AND GOALS, THE IMPROVEMENT OF PATIENT CARE FOR THOSE WITH SPINAL DEFORMITIES. PRESENTATIONS AT THE ANNUAL MEETING & COURSE ARE GIVEN BY LEADING EXPERTS IN THE FIELD AND HAVE VALUE FOR HEALTH CARE PROFESSIONALS WHO TREAT SPINAL DEFORMITIES AT ALL LEVELS AND IN ALL AGES. OVER 100 PAPERS ARE PRESENTED ON AN ARRAY OF TOPICS, INCLUDING ADOLESCENT IDIOPATHIC SCOLIOSIS, GROWING SPINE, KYPHOSIS, ADULT DEFORMITY, TRAUMA, NEUROMUSCULAR SCOLIOSIS AND TUMORS.

Program 3
Expenses: $137,923

SRS COLLABORATES WITH CORPORATE PARTNERS AND THE INTERNATIONAL SPINE STUDY GROUP ON THE ASLS II STUDY. THIS STUDY IS A CONTINATION OF THE ASLS I STUDY WHICH WAS A PROSPECTIVE, RANDOMIZED NIH FUNDED...

Read more

SRS COLLABORATES WITH CORPORATE PARTNERS AND THE INTERNATIONAL SPINE STUDY GROUP ON THE ASLS II STUDY. THIS STUDY IS A CONTINATION OF THE ASLS I STUDY WHICH WAS A PROSPECTIVE, RANDOMIZED NIH FUNDED STUDY THAT EVALUATED THE 2 YEAR TREATMENT OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR ADULT PATIENTS WITH SYMPTOMATIC LUMBAR SCOLIOSIS. ASLS II ALLOWS FOR LONGER TERM FOLLOW UP OF THE PATIENTS IN THE STUDY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,666,885
Program Service Revenue $3,199,518
Investment Income $1,472,534
Other Revenue $-31,680
TOTAL REVENUE $6,307,257

Expense Breakdown

Grants Paid $613,007
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $4,294,666
Other Expenses $5,019,091
TOTAL EXPENSES $5,632,098

Year-over-Year Comparison

2023 2022 Change
Revenue $6,307,257 $7,743,353 -0.2%
Expenses $5,632,098 $5,306,083 +0.1%
Net Income $675,159 $2,437,270 -0.7%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
18
Independent Members
17
Employees
N/A
Volunteers
20

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$40,000
Total Directors
18
$40,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
SERENA S HU MD PAST PRESIDENT 5.00
Officer Director
$40,000 $0 $40,000
LAUREL C BLAKEMORE MD PRESIDENT ELECT 7.00
Officer Director
$0 $0 $0
SUKEN A SHAH MD VICE PRESIDENT 3.00
Officer Director
$0 $0 $0
MARINUS DE KLEUVER MD PHD PRESIDENT 3.00
Officer Director
$0 $0 $0
DAVID SKAGGS MD MMM TREASURER 7.00
Officer Director
$0 $0 $0
FERRAN PELLISE MD PHD SECRETARY 7.00
Officer Director
$0 $0 $0
CHRISTOPHER I SHAFFREY MD PAST PRESIDENT 7.00
Officer Director
$0 $0 $0
MUHARREM YAZICI MD PAST PRESIDENT 2 5.00
Officer Director
$0 $0 $0
MAUNISH GUPTA MD EDUCATION CHAIR 3.00
Director
$0 $0 $0
RON EL-HAWARY MD COMMUNICATION CHAIR 3.00
Director
$0 $0 $0
DOUGLAS BURTON MD RESEARCH CHAIR 3.00
Director
$0 $0 $0
ERIC KLINEBERG MD DIRECTOR 3.00
Director
$0 $0 $0
LINDSAY ANDRAS MD DIRECTOR 3.00
Director
$0 $0 $0
FIROZ JIYANJI MD FRCSC DIRECTOR 3.00
Director
$0 $0 $0
KOTA WATANABE MD PHD DIRECTOR 3.00
Director
$0 $0 $0
EVALINA BURGER MD DIRECTOR 3.00
Director
$0 $0 $0
MICHAEL KELLY MD DIRECTOR 3.00
Director
$0 $0 $0
KHALED KEBAISH MD DIRECTOR 3.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $6,307,257 $5,632,098 $21,328,808 $675,159
2022 $7,743,353 $5,306,083 $19,925,585 $2,437,270
2021 $4,690,080 $3,221,762 $19,613,993 $1,468,318
2020 $3,250,108 $2,744,036 $17,367,746 $506,072
2019 $5,842,920 $5,122,520 $15,810,968 $720,400
2018 $5,937,807 $5,417,694 $13,469,200 $520,113
Explore More Nonprofits
→Top 100 Nonprofits in Wisconsin →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare SCOLIOSIS RESEARCH SOCIETY with other nonprofits in Wisconsin and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.